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Method: A survey addressing training, knowledge, skills and staff confidence to manage FA and anaphylaxis was emailed to 5956 LDCS nationally (excluding WA). 494 surveys were completed. Data was analysed using descriptive statistics and Chi-squared Test.
Results: 76.7% of LDCS had children with a medically confirmed FA. 9.5% of LDCS did not require staff to undertake anaphylaxis training, which was non-compliant with current legislation. Staff confidence in FA and anaphylaxis management was high regardless of whether they had undertaken training, indicating a false level of confidence. 93.9% LDCS had a FA policy requiring Action Plans be provided. 37% LDCS stored AAI in a locked location (not recommended). 51.4% of LDCS reported having an AAI training device. NSW and Queensland had significantly lower proportion of services with AAI training devices than Victoria (Pvalue < 0.001). Victoria reported the highest level of anaphylaxis management training (P-value < 0.05). Victorian services were also significantly less likely to store their AAI devices in a locked location compared to NSW and QLD (P-value < 0.001). There was no significant difference in staff training, knowledge, skills and confidence based on socio-economic status (P-value > 0.05).
Conclusion:
Staff in LDCS self-reported a high level of training, knowledge, skills and confidence in FA and anaphylaxis management. This study revealed gaps in responding to an anaphylaxis emergency, administering an AAI, and storing AAI. Background: The National Allergy Strategy (NAS) food service in hospitals project aims to optimise food allergy (FA) management. Stakeholder engagement indicated that institutions such as hospitals require FA policies, protocols and staff training to ensure appropriate food service for patients with food allergy. To support safe practices and to identify where errors are occurring, appropriate and robust audit processes are required. Currently, there is no legislative or accreditation requirement for hospitals to have FA policies and protocols in place.
Method: The NAS engaged with key stakeholders to identify resource needs to enable the provision of appropriate food for patients with FA in the hospital setting. A working group comprising key stakeholder representation was established to oversee resource development.
Results:
The project has developed and piloted a standardised FA policy template, protocol and audit tool that can be customised to individual health facilities. These easy to access resources will assist health facilities in being compliant with accreditation standards and the Food Standards Code. In addition, a food allergen substitute table and a FA menu assessment tool for use by dietitians were also developed.
Discussion: The resources will be freely accessible and can be customised to individual institutions. The free downloadable FA menu assessment tool for dietitians working with vulnerable populations, developed in partnership with the Dietitians Association of Australia, will enable dietitians to support safe and nutritionally adequate food provision for people with FA in these settings. It is anticipated that these resources can be adapted for use with other vulnerable populations (e.g. aged care, correctional facilities and other residential settings). Background: ASCIA Guidelines for infant feeding and allergy prevention were released in 2016, based on evidence from recently published studies and ASCIA infant feeding advice that was first developed in 2008. The National Allergy Strategy (NAS) identified the need to develop a communication strategy about key recommendations in the 2016 ASCIA Guidelines.
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Method: A social marketing company was engaged to develop four possible brand concepts for focus group testing. Seven focus group sessions (four parent sessions; three health professional sessions) were conducted to determine resource needs and consumer friendly key messages.
Results:
The consumer and health professional focus groups identified 'Nip allergies in the Bub' as the most meaningful brand for consumers and health professionals. A credible, easy to understand website containing relevant information about infant feeding and food allergy prevention was clearly identified as a resource need by parents and health professionals. Health professionals further identified the need for professional resources to exist as a separate component of the website.
Discussion: The NAS Nip allergies in the Bub website aims to provide a public health rather than medicalised approach to infant feeding and food allergy prevention. The website provides information from the ASCIA Guidelines and information about optimising eczema management to prevent food allergy sensitisation, in a consumer friendly format. It contains reliable, easy to find and practical information to help parents follow the ASCIA Guidelines, including ideas to help with the introduction of common food allergens and optimise eczema management. The website also provides an information hub for health professionals including access to new online training and other resources. Method: Implementation of the NAS FAP project comprises four phases: 1-Community website (including website survey) developed based on focus group consultation; 2-MCHN online survey of current infant feeding knowledge and practice; 3-HP education (online training; podcast; pre-post quiz); 4-SmartStartAllergy SMS message system generated through the patient's GP practice. Results: Each phase identified: (1) the need to develop a FAP consumer education website and social marketing strategy; (2) the need to develop FAP education materials for MCHNs; (3) development of HP education resources including FAP e-training (including pre-post quiz to assess knowledge change); (4) development of the SmartStartAllergy SMS program (a modification of the SmartVax), to determine behaviour change (particularly for high risk infants) and monitor allergic reactions to common food allergens in those who choose to participate. During all phases, rates of infant anaphylaxis in Western Australia were monitored real-time, through St John Ambulance.
Discussion: The combined phases of the NAS FAP project provide a comprehensive public health approach to implementing the ASCIA Guidelines. This approach assesses resource requirements, trains health professionals and measures knowledge change. The FAP website provides consumer friendly information to encourage uptake of ASCIA Guidelines with a feedback survey in place to assess the website's effectiveness. A social marketing strategy actively promotes resources, while SmartStartAllergy assesses behaviour change and monitors allergic reactions in participants in addition to the state-wide St John Ambulance infant anaphylaxis monitoring. Shellfish allergy is an increasing global health priority, frequently affecting adults. Molluscs are an important shellfish group causing food allergy but knowledge of their allergens and cross-reactivity is limited. Currently, optimal diagnosis of mollusc allergy enabling accurate advice on food avoidance is difficult. Aims: To assess the IgE reactivity of proteins of four frequently ingested Asia-Pacific mollusc species: Sydney Rock Oyster (Saccostrea glomerata), Blue Mussel (Mytilus edulis), Saucer Scallop (Amusium balloti) and Southern Calamari (Sepioteuthis australis). To examine the effect of heat processing on the IgE reactivity. To determine the level of cross-reactivity between mollusc species and cross-reactivity with Blue Swimmer Crab tropomyosin, Por p 1.
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Methods and Results: Sera from 13 mollusc-sensitised, seafood-allergic subjects (mean age 33.8AE9.2 years; 10F/3M) were assessed for IgE reactivity with mollusc extracts. Cooking of the molluscs increased IgE reactivity as measured by IgE ELISA and immunoblotting. Biologically relevant IgE reactivity was confirmed by basophil activation. Strong IgE reactivity of several proteins including a 37-40 kDa protein corresponding to the major shellfish allergen, tropomyosin, was observed for all species by immunoblotting. IgE-reactive Sydney Rock Oyster proteins were identified by mass spectrometry, and the novel major oyster allergen, tropomyosin Sac g 1, was cloned, sequenced and registered with the IUIS. Oyster extracts showed the highest cross-reactivity with other molluscs, while mussel crossreactivity was weakest. Inhibition IgE immunoblotting demonstrated high cross-reactivity between tropomyosins of mollusc and crustacean species.
Conclusion: These findings inform novel approaches for reliable diagnosis and improved management of mollusc allergy. Results: There were 1140 accidental AAI injections (all EpiPen or EpiPen Junior) over the 6 year period (a rate of 2 accidental AAI injections per 1,000 AAI prescription per year). 58% were male, 64% occurred in children, and in most cases the accidental injection was by the allergic child or by their sibling. The majority of cases (95%) were managed at home. Most injections occurred in the thumb/finger (41%), palm (14%) or thigh (5%). Usually no symptoms were reported (55%), although local pain (23%), pallor (8%) and paraesthesia (4%) were not uncommon. PICs usually suggested local measures only (98%) (immersion in warm water and/or massage), and in 1.8% of cases GTN to the affected area was suggested.
Conclusion: Accidental AAI injection is not uncommon and likely underreported. Digits are the most common site injected, but symptoms are mild, and in most cases local measures are only required. We suggest ASCIA Anaphylaxis Action Plans to be updated to contact PICs if accidental AAI injection occurs. Aim: To ascertain the patient characteristics, geographic location and Jack Jumper ant venom IgE of paediatric patients with Jack Jumper ant allergy reviewed in a tertiary public children's and two private allergy outpatient clinics. To refer all patients (if not already done so) with suspected anaphylaxis for venom immunotherapy.
Method:
We reviewed the medical records of all patients with Jack Jumper ant allergy referred to the Royal Children's Hospital, Epworth Healthcare and Melbourne Allergy Centre and Children's Specialists.
Results: There were 116 patients referred with jack jumper allergy with 227 documented stings. There were 70 confirmed episodes of anaphylaxis. There was no correlation between ssIgE level, co-morbidity and risk of anaphylaxis. The majority of stings occurred in rural Victoria, predominantly in the Central-Northern region. All patients with suspected jack jumper anaphylaxis were referred for venom immunotherapy.
Conclusion: Jack jumper ant allergy is a significant problem in the paediatric population. Venom immunotherapy should be considered for all cases of confirmed anaphylaxis. 
